Hedge fund group Man sees assets under management swell to a record, announces new buyback February 29, 2024 Man Group, the world's largest publicly listed hedge fund, has hit a record in assets under management despite a sharp fall in annual profits on lower performance fees.
London Stock Exchange owner pledges ‘aggressive’ IPO push after ‘encouraging’ signs of revival February 29, 2024 The owner of the London Stock Exchange said it was seeing an “encouraging IPO pipeline” for the year ahead today as it looks to rebound from a historic slump in listings last year.
Hamilton Lane: Why retail investors should be diving into private markets February 29, 2024 The new co-CEO of Hamilton Lane has one goal: getting retail investors excited about private markets.
FCA under fire for ‘sinister’ plans to ‘name and shame’ firms February 28, 2024 City lawyers have launched a broadside on the Financial Conduct Authority today for what they call “sinister” plans to change enforcement rules that could unfairly damage the reputation of firms.
Is there anything good in St James’s Place’s results? February 28, 2024 Britain’s biggest wealth manager St James's Place saw its stock price hit its lowest since December 2012 this morning on the back of a gruelling 2023 results.
St James’s Place shares plummet as bosses set aside £426m for complaints February 28, 2024 Wealth manager St James’s Place said it had been a “challenging” year today as its cash result cratered on the back of an overhaul in its fee structure and provisions for a deluge of complaints.
Abrdn hands chief £800k bonus as profits dip and clients pull £13.9bn February 27, 2024 Fund manager Abrdn has handed chief executive Stephen Bird a near £800k bonus despite clients pulling out even more funds, leading to a dip in annual profits.
Audit watchdog set to shake-up stewardship code to focus on ‘growth’ February 27, 2024 The audit watchdog is set to shake up the so-called stewardship code governing the UK’s top investors as pressure mounts on regulators to strip back red tape and support “growth and the UK’s competitiveness”.
British Patient Capital invests £10m into biotech firm developing cancer drug discovery platform February 27, 2024 British Patient Capital, the venture capital subsidiary of UK government-owned British Business Bank, has invested £10m into biotech firm Curve Therapeutics to support its cancer drug discovery technology.
Robinhood rival Public.com shuttering UK business just eight months after launch February 26, 2024 Robinhood rival Public.com is shuttering its UK business just nine months after launch, the firm has told its customers today.